<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Daley MF</submitter><funding>Intramural CDC HHS</funding><pagination>37-46</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10109516</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(1)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To assess the association between cumulative aluminum exposure from vaccines before age 24 months and persistent asthma at age 24 to 59 months.&lt;h4>Methods&lt;/h4>A retrospective cohort study was conducted in the Vaccine Safety Datalink (VSD). Vaccination histories were used to calculate cumulative vaccine-associated aluminum in milligrams (mg). The persistent asthma definition required one inpatient or 2 outpatient asthma encounters, and ≥2 long-term asthma control medication dispenses. Cox proportional hazard models were used to evaluate the association between aluminum exposure and asthma incidence, stratified by eczema presence/absence. Adjusted hazard ratios (aHR) and 95% confidence intervals (CI) per 1 mg increase in aluminum exposure were calculated, adjusted for birth</pubmed_abstract><journal>Academic pediatrics</journal><pubmed_title>Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months.</pubmed_title><pmcid>PMC10109516</pmcid><funding_grant_id>CC999999</funding_grant_id><pubmed_authors>Getahun D</pubmed_authors><pubmed_authors>Nordin JD</pubmed_authors><pubmed_authors>McClure DL</pubmed_authors><pubmed_authors>Daley MF</pubmed_authors><pubmed_authors>Irving SA</pubmed_authors><pubmed_authors>Duffy J</pubmed_authors><pubmed_authors>Jackson ML</pubmed_authors><pubmed_authors>Kamidani S</pubmed_authors><pubmed_authors>Reifler LM</pubmed_authors><pubmed_authors>Klein NP</pubmed_authors><pubmed_authors>Hambidge SJ</pubmed_authors><pubmed_authors>DeStefano F</pubmed_authors><pubmed_authors>Glanz JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months.</name><description>&lt;h4>Objective&lt;/h4>To assess the association between cumulative aluminum exposure from vaccines before age 24 months and persistent asthma at age 24 to 59 months.&lt;h4>Methods&lt;/h4>A retrospective cohort study was conducted in the Vaccine Safety Datalink (VSD). Vaccination histories were used to calculate cumulative vaccine-associated aluminum in milligrams (mg). The persistent asthma definition required one inpatient or 2 outpatient asthma encounters, and ≥2 long-term asthma control medication dispenses. Cox proportional hazard models were used to evaluate the association between aluminum exposure and asthma incidence, stratified by eczema presence/absence. Adjusted hazard ratios (aHR) and 95% confidence intervals (CI) per 1 mg increase in aluminum exposure were calculated, adjusted for birth</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan-Feb</publication><modification>2025-04-04T03:00:27.313Z</modification><creation>2025-04-04T03:00:27.313Z</creation></dates><accession>S-EPMC10109516</accession><cross_references><pubmed>36180331</pubmed><doi>10.1016/j.acap.2022.08.006</doi></cross_references></HashMap>